These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26242050)

  • 1. [Phosphodiesterase type 5 inhibitors for premature ejaculation: advances in studies].
    Mo DS; Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2015 Jun; 21(6):561-5. PubMed ID: 26242050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress of combination therapy in the treatment of erectile dysfunction and premature ejaculation comorbidity].
    Peng J; Zhang ZC
    Zhonghua Nan Ke Xue; 2023 Sep; 29(9):771-775. PubMed ID: 38639587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.
    Abdel-Hamid IA
    Drugs; 2004; 64(1):13-26. PubMed ID: 14723556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effects of α1-adrenoceptor antagonism and L-type calcium channel blockade on ejaculation and vas deferens and seminal vesicle contractility in vitro.
    de Almeida Kiguti LR; Pupo AS
    J Sex Med; 2012 Jan; 9(1):159-68. PubMed ID: 21810189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation.
    Wang WF; Minhas S; Ralph DJ
    Int J Androl; 2006 Oct; 29(5):503-09. PubMed ID: 16573707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? a systematic review and meta-analysis.
    Asimakopoulos AD; Miano R; Finazzi Agrò E; Vespasiani G; Spera E
    J Sex Med; 2012 Sep; 9(9):2404-16. PubMed ID: 22248110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors for premature ejaculation: review of erectile and ejaculatory side effects.
    Lasker GF; Halis F; Gokce A
    Curr Drug Saf; 2014; 9(2):118-26. PubMed ID: 24446888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data.
    Chen J; Keren-Paz G; Bar-Yosef Y; Matzkin H
    Eur Urol; 2007 Nov; 52(5):1331-9. PubMed ID: 17728050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation.
    Jannini EA; McMahon C; Chen J; Aversa A; Perelman M
    J Sex Med; 2011 Aug; 8(8):2135-43. PubMed ID: 21791006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective evaluation of the efficacy of daily paroxetine/tadalafil combination in patients with premature ejaculation and erectile dysfunction.
    Onal B; Can O; Ermec B; Culha MG
    Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4248-4253. PubMed ID: 37203851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction.
    Karabakan M; Keskin E; Akdemir S; Bozkurt A
    Int Braz J Urol; 2017; 43(2):317-324. PubMed ID: 27819758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New data on the effectiveness of Tadalafil alone and in combination with NeyroDoz in treating erectile dysfunction associated with secondary premature ejaculation].
    Akhvlediani ND; Matyukhov IP
    Urologiia; 2016 Nov; (5):52-56. PubMed ID: 28248021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    Seftel AD
    J Urol; 2014 Apr; 191(4):1077-8. PubMed ID: 24703142
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphodiesterase-5 Inhibitors for Premature Ejaculation: Systematic Review and Meta-Analysis of Placebo-Controlled Trials.
    Zhang X; Chi N; Sun M; Shan Z; Zhang Y; Cui Y
    Am J Mens Health; 2020; 14(3):1557988320916406. PubMed ID: 32375542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Phosphodiesterase-5 Inhibitor in Men With Premature Ejaculation: A New Systematic Review and Meta-analysis.
    Sun Y; Luo D; Yang L; Tang C; Yang T; Hu X; Shen H
    Urology; 2015 Nov; 86(5):947-54. PubMed ID: 26278825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to Pero Bokarica's letter to the editor re: K. Hatzimouratidis, I. Eardley, F. Giuliano, I. Moncada, A. Salonia. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology Website. http://uroweb.org/guideline/male-sexual-dysfunction/. Updated 2015.
    Hatzimouratidis K
    Eur Urol; 2015 Oct; 68(4):e78. PubMed ID: 26138039
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil.
    Paduch DA; Bolyakov A; Beardsworth A; Watts SD
    BJU Int; 2012 Apr; 109(7):1060-7. PubMed ID: 21883853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the studies of refractory erectile dysfunction].
    Wang BY; Jiang R
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):82-5. PubMed ID: 23469669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: K. Hatzimouratidis, I. Eardley, F. Giuliano, I. Moncada, A. Salonia. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology Web site. http://uroweb.org/guideline/male-sexual-dysfunction/. Updated 2015.
    Bokarica P
    Eur Urol; 2015 Oct; 68(4):e77. PubMed ID: 26138038
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the expression and contractile function of α1-adrenoceptors in seminal vesicle and vas deferens from normotensive and hypertensive rats.
    Yono M; Tanaka T; Tsuji S; Hori M; Irie S; Sakata Y; Otani M; Yoshida M; Latifpour J
    Eur J Pharmacol; 2012 Nov; 694(1-3):104-10. PubMed ID: 22960063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.